Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Morphic Holding Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MORF
Nasdaq
2834
https://morphictx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Morphic Holding Inc
Morphic Holding Insiders Placed Bullish Bets Worth US$47.3m
- Mar 21st, 2024 1:43 pm
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
- Mar 19th, 2024 12:00 pm
Morphic to Participate in March Investor Conferences
- Mar 5th, 2024 9:05 pm
Wall Street Analysts See a 56.18% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High?
- Feb 26th, 2024 2:55 pm
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
- Feb 22nd, 2024 12:00 pm
Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 57.22%: Read This Before Placing a Bet
- Feb 8th, 2024 2:55 pm
Morphic Holding Inc CEO Praveen Tipirneni Sells 13,923 Shares
- Jan 18th, 2024 6:04 am
Wall Street Analysts Believe Morphic Holding, Inc. (MORF) Could Rally 110.28%: Here's is How to Trade
- Jan 5th, 2024 2:55 pm
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 9:05 pm
Does Morphic Holding, Inc. (MORF) Have the Potential to Rally 92.88% as Wall Street Analysts Expect?
- Dec 20th, 2023 2:55 pm
Wall Street Analysts See a 150.17% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High?
- Dec 1st, 2023 2:55 pm
We're Not Very Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Rate
- Nov 23rd, 2023 10:45 am
Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 160.84%: Read This Before Placing a Bet
- Nov 15th, 2023 2:55 pm
Morphic to Present at November Investor Conferences
- Nov 10th, 2023 1:00 pm
Morphic Holding, Inc. (MORF) Moves to Buy: Rationale Behind the Upgrade
- Nov 9th, 2023 5:00 pm
Morphic Holding Inc (MORF) Reports Q3 2023 Loss of $36.2 Million, Ends Quarter with $725. ...
- Nov 3rd, 2023 12:46 pm
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
- Nov 3rd, 2023 11:00 am
This Morphic Holding Insider Increased Their Holding By 16% Last Year
- Oct 13th, 2023 1:03 pm
Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
- Oct 9th, 2023 12:00 pm
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
- Sep 26th, 2023 8:10 pm
Scroll